Brg1 and npm-alk are co-regulated in anaplastic large-cell lymphoma; brg1 is a potential therapeutic target in alcl

Gavin D. Garland; Stephen P. Ducray; Leila Jahangiri; Perla Pucci; G. A.Amos Burke; Jack Monahan; Raymond Lai; Olaf Merkel; Ana Iris Schiefer; Lukas Kenner; Andrew J. Bannister; Suzanne D. Turner

doi:10.3390/cancers14010151

Brg1 and npm-alk are co-regulated in anaplastic large-cell lymphoma; brg1 is a potential therapeutic target in alcl

Gavin D. Garland, Stephen P. Ducray, Leila Jahangiri, Perla Pucci, G. A.Amos Burke, Jack Monahan, Raymond Lai, Olaf Merkel, Ana Iris Schiefer, Lukas Kenner, Andrew J. Bannister, Suzanne D. Turner^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

4 Citations (SciVal)

Original language	English
Article number	151
Journal	Cancers
Volume	14
Issue number	1
DOIs	https://doi.org/10.3390/cancers14010151
Publication status	Published (VoR) - 1 Jan 2022

Funding

Funding: This research was funded by European Union Marie Sklordowski Curie Innovative Training Network ALKATRAS, grant number 675712. S.D.T. receives funding from the CRUK Cambridge Centre Major Centre Award, grant number C9685/A25117. A.J.B. is supported by grants from Cancer Research UK (RG96894 and C6946/A24843) and the Wellcome Trust (WT203144).

Keywords

ALCL
Brg1
NPM-ALK

Access to Document

10.3390/cancers14010151

Cite this

@article{b5d72bbdd55042a5a1eb1105b1ff9d55,

title = "Brg1 and npm-alk are co-regulated in anaplastic large-cell lymphoma; brg1 is a potential therapeutic target in alcl",

keywords = "ALCL, Brg1, NPM-ALK",

author = "Garland, \{Gavin D.\} and Ducray, \{Stephen P.\} and Leila Jahangiri and Perla Pucci and Burke, \{G. A.Amos\} and Jack Monahan and Raymond Lai and Olaf Merkel and Schiefer, \{Ana Iris\} and Lukas Kenner and Bannister, \{Andrew J.\} and Turner, \{Suzanne D.\}",

note = "Funding Information: Funding: This research was funded by European Union Marie Sklordowski Curie Innovative Training Network ALKATRAS, grant number 675712. S.D.T. receives funding from the CRUK Cambridge Centre Major Centre Award, grant number C9685/A25117. A.J.B. is supported by grants from Cancer Research UK (RG96894 and C6946/A24843) and the Wellcome Trust (WT203144). Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = jan,

day = "1",

doi = "10.3390/cancers14010151",

language = "English",

volume = "14",

journal = "Cancers",

issn = "2072-6694",

publisher = "MDPI",

number = "1",

}

TY - JOUR

T1 - Brg1 and npm-alk are co-regulated in anaplastic large-cell lymphoma; brg1 is a potential therapeutic target in alcl

AU - Garland, Gavin D.

AU - Ducray, Stephen P.

AU - Jahangiri, Leila

AU - Pucci, Perla

AU - Burke, G. A.Amos

AU - Monahan, Jack

AU - Lai, Raymond

AU - Merkel, Olaf

AU - Schiefer, Ana Iris

AU - Kenner, Lukas

AU - Bannister, Andrew J.

AU - Turner, Suzanne D.

N1 - Funding Information: Funding: This research was funded by European Union Marie Sklordowski Curie Innovative Training Network ALKATRAS, grant number 675712. S.D.T. receives funding from the CRUK Cambridge Centre Major Centre Award, grant number C9685/A25117. A.J.B. is supported by grants from Cancer Research UK (RG96894 and C6946/A24843) and the Wellcome Trust (WT203144). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2022/1/1

Y1 - 2022/1/1

KW - ALCL

KW - Brg1

KW - NPM-ALK

UR - https://www.scopus.com/pages/publications/85121802278

UR - https://www.scopus.com/inward/citedby.url?scp=85121802278&partnerID=8YFLogxK

U2 - 10.3390/cancers14010151

DO - 10.3390/cancers14010151

M3 - Article

AN - SCOPUS:85121802278

SN - 2072-6694

VL - 14

JO - Cancers

JF - Cancers

IS - 1

M1 - 151

ER -

Brg1 and npm-alk are co-regulated in anaplastic large-cell lymphoma; brg1 is a potential therapeutic target in alcl

Funding

Keywords

Access to Document

Other files and links

Fingerprint

Cite this